Microsoft Corporation (NASDAQ:MSFT)  is working on a technology through which ear buds will monitor heart rate, temperature and other biorhythms to get the exact condition of one’s health and mood. Microsoft Corporation (NASDAQ:MSFT) is trying to develop such ear buds under a project called Septimu.


Microsoft Septimu Underway

University of Virginia Center for Wireless Health researchers have developed a smartphone app called Musical Heart for Septimu earbuds, according to CyThings blog.

Musical heart will recognize the biorhythms and will play the music accordingly. For instance, if a person is upset and feeling restless, and his heart are beating fast then it will pick up  music that can calm him down. Similarly, if a person wants to maintain stable heartbeat, then the app will select that kind of music. These projects, as of now, are under research.

The ear bud has an internal microphone that tracks one’s heart rate and sound signals. Inertial Measurement Unit (IMU) is fixed on the ear buds, through which a smartphone will be able to collect information on the activity and health conditions of the user.

Other similar apps

Mico earphones from Neurowear can trail brainwaves and recognize the user’s mood. The earphones connect the brainwaves with a music app and music database to pick up an apt song for the specific mood of the user.

Biobeats is an Apple iPhone app that can port the user’s heartbeat into suitable sounds on the iPhone to calm him or her down. The iPhone user has to touch the smartphone’s camera, and lights passing through fingers helps the app to detect the change as blood flows though the veins. Through this app, the heart rate of the user can be estimated. Recently Biobeats performed an interesting experiment with hip pop crew Far East Movement in which around 1.5 million users’ heartbeat were linked and seen live.

Analyst take on Microsoft

Recently, analysts at The Street assigned a Buy rating to Microsoft Corporation (NASDAQ:MSFT) in a research note issued to the investors on October 14, 2013. UBS AG analysts have assigned a Buy rating to the stock with a price target of $37.00, in a report last week. Separately, CitiGroup analysts have maintained their Buy rating in a research note to  investors on September 20th. Overall, Microsoft has an average rating of Hold and an average price target of $33.55.